A new study describes the development of a cAMP analogue that specifically activates only Epac2, one of several cAMP-responsive proteins. Furthermore, the analogue activates Epac2 more potently than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback